What You Should Know:
- Precision medicine company CareDx acquires MediGO, an organ transplant supply chain and logistics company for an undisclosed sum.
- The strategic acquisition will expand CareDx’s digital health portfolio to serve the organ procurement organization (OPO) market while also bolstering its pre-transplant offerings aimed at shortening transplant wait times and increasing access to donated organs.
Enhancing Organ Procurement
The organ recovery and transplant industries are highly fragmented, and the transplant industry cannot scale with the current infrastructure. MediGO is digitally transforming donation and transplantation workflows to increase organ utilization and save more lives. Our solutions optimize complex logistics from referral to recovery and during the critical movement of organs and teams. The MediGO acquisition provides a unique and strategic advantage for CareDx and the industry as a whole to further strengthen and enable the growth of organ procurement by increasing volume of transplantation with the goal of eliminating the waitlist of organs, improving the patient journey, and ultimately saving lives.
“We are thrilled to join forces with CareDx. CareDx and MediGO hold shared values and a mission to deliver transformational solutions that improve the transplant patient journey,” said Scott Plank, Executive Chairman and Founder of MediGO. “Combining MediGO’s network, real-time data, and predictive analytics with CareDx’s digital health platform capabilities, we are better poised to deliver next-generation data-driven patient solutions. With MediGO’s people and technology solutions and CareDx, we expect to make a greater impact through this collaboration. We look forward to expanding our current offerings to OPOs, couriers, and hospitals, and scaling the organ transplant system to deliver lifesaving organs and better outcomes for all who need them.”